Menu
Back to Blog
treatments 7 min read

Stem Cell Therapy for Joint Pain: An Evidence-Based Review

Explore the current evidence on stem cell therapy for arthritis and joint pain. Learn what science actually shows, costs, risks, and what to expect from this emerging treatment.

By Joint Pain Authority Team

Stem Cell Therapy for Joint Pain: An Evidence-Based Review

Key Takeaways

  • Stem cell therapy for joints is still experimental—not FDA-approved for arthritis
  • Early research shows promise, but high-quality evidence is limited
  • Costs range from $5,000-$25,000+ and are not covered by insurance
  • Many clinics make claims that exceed the current evidence
  • Results vary widely, and there are no guarantees
  • Established treatments should typically be tried first

Stem cell therapy generates enormous hope for people with joint pain. The idea of regenerating damaged cartilage and reversing arthritis is tremendously appealing. But what does the science actually show?

This guide examines the current state of evidence, helping you separate legitimate research from marketing hype.

What Is Stem Cell Therapy?

The Concept

Stem cells are undifferentiated cells capable of becoming various specialized cell types. The theory behind stem cell therapy for joints is that injecting these cells might:

  • Regenerate damaged cartilage
  • Reduce inflammation
  • Repair injured tissues
  • Slow or reverse arthritis progression

Types of Cells Used

Bone marrow-derived stem cells (BMSCs):

  • Harvested from the patient’s hip bone
  • Processed to concentrate stem cells
  • Reinjected into the affected joint

Adipose-derived stem cells (ADSCs):

  • Harvested from the patient’s fat tissue (mini-liposuction)
  • Processed and concentrated
  • Reinjected into the joint

Umbilical cord/placental products:

  • Obtained from donor tissue (after birth)
  • May contain growth factors and other cells
  • FDA has expressed concerns about many of these products

PRP (Platelet-Rich Plasma):

  • Not stem cells, but often discussed alongside them
  • Concentrated platelets from patient’s own blood
  • Contains growth factors

What Does the Evidence Show?

The Challenge of Research

Studying stem cell therapy is challenging because:

  • No standardized protocols exist
  • Cell preparations vary widely between clinics
  • Patient populations differ between studies
  • Placebo effects are significant for pain outcomes
  • Most studies are small and lack control groups

Current Research Summary

Positive findings:

  • Some studies show pain improvement compared to baseline
  • A subset of patients report significant benefit
  • Early-stage arthritis may respond better than severe disease
  • Treatments appear generally safe in the short term

Limitations:

  • Few high-quality randomized controlled trials
  • Many studies lack proper control groups
  • Placebo injections also often improve symptoms
  • Evidence of actual cartilage regeneration is weak
  • Long-term outcomes are largely unknown

Specific Findings

For knee osteoarthritis:

  • Several studies show modest pain improvement
  • Benefits may not exceed other injections (like hyaluronic acid)
  • Cartilage regeneration on MRI is inconsistent
  • Best results in early to moderate arthritis

For other joints:

  • Less research available
  • Hip and shoulder studies are limited
  • Evidence is insufficient to draw conclusions

What the FDA Says

Current Regulatory Status

The FDA has not approved any stem cell therapy for treating arthritis or joint pain.

Key points:

  • Autologous cells (your own) minimally manipulated may be legal
  • Heavily processed or cultured cells require FDA approval
  • Many clinics operate in regulatory gray areas
  • The FDA has taken action against clinics making unsupported claims

Warning Signs

The FDA warns against clinics that:

  • Promise to cure arthritis or other diseases
  • Claim treatments are “FDA-approved” for arthritis
  • Use unproven products from other countries
  • Charge exorbitant fees for experimental treatments

Costs and Insurance

Typical Costs

  • Range: $5,000-$25,000+ per treatment
  • Average: $8,000-$15,000 for a single joint
  • Factors affecting cost: Cell source, processing, location, clinic

Insurance Coverage

  • Medicare: Does not cover stem cell therapy for joints
  • Private insurance: Generally does not cover (considered experimental)
  • Out-of-pocket: Most patients pay entirely themselves

Cost Considerations

Before paying thousands for stem cell therapy:

  • Have you tried established treatments?
  • What is the clinic’s success rate?
  • What happens if it doesn’t work?
  • Could this money be better spent on proven treatments?

Choosing a Clinic (If You Decide to Proceed)

Questions to Ask

  1. What type of cells are used?

    • Autologous (your own) vs. donor
    • Source (bone marrow, fat, other)
  2. What is your success rate?

    • How do they measure success?
    • Do they have outcome data?
  3. What are the risks?

    • Every procedure has risks
    • Be wary of clinics that claim no risks
  4. Who performs the procedure?

    • Physician credentials
    • Training and experience
  5. What follow-up is provided?

    • Post-procedure monitoring
    • What if it doesn’t work?

Red Flags

Be cautious of clinics that:

  • Guarantee results
  • Pressure you to decide immediately
  • Offer discounts for same-day decisions
  • Claim to treat many unrelated conditions with the same therapy
  • Have minimal physician involvement
  • Won’t provide outcome data

Risks and Complications

Known Risks

From the injection:

  • Infection
  • Bleeding
  • Pain at injection site
  • Joint inflammation

From cell processing:

  • Contamination
  • Cell viability issues
  • Inconsistent preparations

Potential concerns:

  • Unknown long-term effects
  • Theoretical risk of tumor formation (though not documented in reputable studies)
  • Wasted money if ineffective

Safety Profile

When performed at reputable facilities using autologous cells:

  • Short-term safety appears acceptable
  • Serious complications are rare
  • Long-term safety data is limited

Current Recommendations

Medical Society Positions

American Academy of Orthopaedic Surgeons (AAOS):

  • Considers stem cell therapy for OA to be investigational
  • Recommends against routine use outside of clinical trials
  • Encourages participation in well-designed research

American College of Rheumatology:

  • Notes insufficient evidence for routine recommendation
  • Acknowledges ongoing research interest

Practical Guidance

Consider stem cell therapy cautiously if:

  • You’ve exhausted conventional treatments
  • You have early to moderate arthritis (not bone-on-bone)
  • You understand the experimental nature
  • You can afford it without financial hardship
  • You choose a reputable provider

Think twice if:

  • You haven’t tried established treatments
  • A clinic promises miraculous results
  • You’d go into debt for the treatment
  • You have severe, end-stage arthritis
  • The clinic uses unproven products

Alternative Established Treatments

Before considering stem cell therapy, ensure you’ve optimized:

  • Exercise and physical therapy: Still the foundation of arthritis treatment
  • Weight management: Significant impact on knee and hip OA
  • Medications: NSAIDs, acetaminophen, topical treatments
  • Injections: Corticosteroids, hyaluronic acid
  • Assistive devices: Braces, supports, mobility aids
  • Surgery: When appropriate, joint replacement is highly effective

The Future

Ongoing Research

Stem cell therapy for joints remains an active research area:

  • Better cell preparation protocols are being developed
  • Clinical trials are ongoing
  • Understanding of mechanisms is improving
  • Combination approaches are being explored

Realistic Expectations

Even if stem cell therapy proves effective:

  • It’s unlikely to be a “cure” for arthritis
  • Benefits may be modest rather than dramatic
  • It will probably work better for some patients than others
  • Cost and access will remain issues

Frequently Asked Questions

Can stem cells regrow cartilage?

Evidence of actual cartilage regeneration is limited and inconsistent. While some studies show improvements on MRI, it’s unclear whether meaningful cartilage regrowth occurs. Benefits may come from anti-inflammatory effects rather than regeneration.

How many treatments are needed?

Protocols vary widely. Some clinics recommend single treatments; others suggest series. There’s no evidence-based standard. Be wary of clinics that prescribe expensive treatment series without clear rationale.

How long do results last?

Unknown. Most studies have short follow-up periods (1-2 years). Long-term durability is not established. Some patients report benefits lasting years; others experience minimal or temporary improvement.

Is stem cell therapy better than joint replacement?

For end-stage arthritis, joint replacement is a proven, highly effective treatment. Stem cell therapy has not been shown to be an alternative to joint replacement for severe arthritis. The treatments address different patient populations.

Should I try PRP or stem cells?

PRP has more research behind it and is less expensive. For patients interested in regenerative approaches, PRP might be a reasonable first step. However, evidence for PRP is also mixed.


Looking for established treatment options? Explore our guides on hyaluronic acid injections or read about when knee replacement is necessary.

Last medically reviewed: February 2025

Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Stem cell therapy for joints is experimental. Discuss any treatment decisions with your healthcare provider.

Enjoyed this article?

Get more insights like this delivered to your inbox weekly.

You're in! Check your inbox.

Join 10,000+ readers. No spam.

Your Next Steps

What's Your Next Step?

You've learned about stem cell therapy for joint pain: an evidence-based review. Here's how to move forward:

Have questions? Contact us or call 1-800-555-0123